Participants:18–64 years · 65+ years
Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol

Contact Research Centre

Chronic rhinosinusitis with nasal polyps

Not recruiting

Registered drugNo placebo

Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cabotegravir

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:RO7284755

Contact Research Centre

Multiple system atrophy

Not recruiting

Investigational

Study of Amlenetug for Patients with Multiple System Atrophy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:AMLENETUG

Contact Research Centre

Primary mediastinal large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Primary Mediastinal B-Cell Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Axicabtagene Ciloleucel

Contact Research Centre

Uveitis+1

Not recruiting

Registered drug

Study on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Breast cancer+4

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Find therapies in clinical trials near you – page 22

406 trials match your criteria

VEXAS syndrome

Study of pacritinib effectiveness and safety compared to placebo in patients with VEXAS syndrome

Multiple sclerosis

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Chronic rhinosinusitis with nasal polyps

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Interstitial lung disease+1

Study to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases

Chronic rhinosinusitis with nasal polyps

Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

Hormone receptor positive HER2 negative breast cancer

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

HIV infection

Study on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment

Bladder transitional cell carcinoma

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Multiple system atrophy

Study of Amlenetug for Patients with Multiple System Atrophy

Primary mediastinal large B-cell lymphoma

Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Primary Mediastinal B-Cell Lymphoma

Uveitis+1

Study on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis

Breast cancer+4

Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.